Tufts Health Plan monitors communications about novel H1N1 influenza from federal government and federal public health agencies. The information below is current as of November 9, 2009, and will be updated as additional information is available.
Antiviral Guidance and Health Advisory
The CDC has issued a one-page document titled Quick Facts for Clinicians on Antiviral Treatments for 2009 H1N1. This summary sheet includes important information to clear up some common misconceptions about the timing and appropriate use of antiviral medications for H1N1 flu. Influenza antiviral medications can reduce the severity and duration of the illness and can reduce the risk of influenza-related complications, including severe illness and death.
Key Issues for Clinicians Concerning Antiviral Treatments for 2009 H1N1, produced by the Health Alert Network CDC Health Advisory, notes that not all people recommended for antiviral treatment are being treated. The document provides facts for clinicians to consider when deciding whether a patient needs to be treated with antiviral medication.
Tufts Health Plan has suspended the Tamiflu (oseltamivir) dispensing limits for all members younger than age 18. The dispensing limit remains in place for members age 18 and older.
Vaccine Availability
The federal government will provide states with H1N1 vaccine and supplies at no cost.
The Massachusetts Department of Public Health (MDPH) will be responsible for directing the shipment of all H1N1 vaccine in the Commonwealth. All public and private provider sites interested in receiving and administering H1N1 vaccine must register online at the MDPH Web site.
The State of Rhode Island Department of Health requires every facility that will store and administer the H1N1 vaccine to register online at their Web site. All providers who treat patients with chronic, underlying medical conditions are strongly encouraged to enroll so that patients at the highest risk for complications from H1N1 influenza can be vaccinated.
Who Should be Vaccinated
Based on the epidemiology of the H1N1 influenza virus, the CDC has issued recommendations that the following populations receive H1N1 vaccine: